A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.

A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.

Item
http://www.wikidata.org/entity/Q40663647
A systematic review of modelling approaches in economic evaluations of health interventions for drug and alcohol problemsEconomic outcomes of the obese patient.ABC of obesity. Management: part II--drugs.Orlistat in responding obese type 2 diabetic patients: meta-analysis findings and cost-effectiveness as rationales for reimbursement in Sweden and Switzerland.Cost-effectiveness of pharmacological anti-obesity treatments: a systematic review.Economic evaluations of adult weight management interventions: a systematic literature review focusing on methods used for determining health impacts.Meta- and cost-effectiveness analysis of commercial weight loss strategies.Cost-effectiveness of orlistat for the treatment of overweight and obese patients in Ireland.Health economic evaluation of controlled and maintained physical exercise in the prevention of cardiovascular and other prosperity diseases.
P2860

A health economic model to assess the long-term effects and cost-effectiveness of orlistat in obese type 2 diabetic patients.

Item
http://www.wikidata.org/entity/Q40663647
description
2002 nî lūn-bûn
@nan
2002年の論文
@ja
2002年論文
@yue
2002年論文
@zh-hant
2002年論文
@zh-hk
2002年論文
@zh-mo
2002年論文
@zh-tw
2002年论文
@wuu
2002年论文
@zh
2002年论文
@zh-cn
name
A health economic model to ass ...... bese type 2 diabetic patients.
@en
type
label
A health economic model to ass ...... bese type 2 diabetic patients.
@en
prefLabel
A health economic model to ass ...... bese type 2 diabetic patients.
@en
P1433
P1476
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921
P356
P1433
P1476
A health economic model to ass ...... bese type 2 diabetic patients.
@en
P2093
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P921